Providing Education on the Therapeutic
Use of Psilocybin
Providing Education on the Therapeutic
Use of Psilocybin
Psilocybin and psychedelic compounds can improve quality of life
Our understanding of psilocybin, its mechanisms of action and potential therapeutic targets, is rapidly evolving. Research and clinical evidence demonstrate that psilocybin can be safely used for improving patient outcomes.
When used in treating specific psychological conditions, psilocybin and other psychedelic compounds have the potential to reduce polypharmacy and undesireable pharmaceutical side effects.
REVIEW Article
Therapeutic use of psilocybin: Practical considerations for dosing and administration
Citation
Front. Psychiatry, 01 December 2022
Sec. Addictive Disorders
https://doi.org/10.3389/fpsyt.2022.1040217
Authors
Caroline A. MacCallum1, Lindsay A. Lo2, Carly A. Pistawka3 and Jagpaul Kaur Deol4
1Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
2Department of Public Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
3Faculty of Science, University of British Columbia, Vancouver, BC, Canada
4Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
Abstract
The interest in psilocybin as a therapeutic approach has grown exponentially in recent years. Despite increasing access, there remains a lack of practical guidance on the topic for health care professionals. This is particularly concerning given the medical complexity and vulnerable nature of patients for whom psilocybin-assisted psychotherapy may be considered. This article aims to provide health care professionals with an overview of practical considerations for psilocybin therapy, rooted in a patient safety focus. Within this piece we will review basic psilocybin pharmacology and pharmacokinetics, indications, practical therapeutic strategies (e.g., dosing, administration, monitoring) and safety considerations (e.g., contraindications, adverse events, and drug interactions). With this information, our goal is to increase the knowledge and comfort of health care professionals to discuss and counsel their patients on psilocybin therapy, ultimately improving patient care and safety.
Featured on
Huberman Lab Podcast
How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks
Huberman Lab Podcast
Published May 8, 2023
In this episode, Andrew Huberman discusses what psilocybin is (chemically) and how it works at the cellular and neural circuit level to trigger neuroplasticity, which is our brain’s ability to rewire itself in ways that lead to long-lasting shifts in our emotional, cognitive and behavioral patterns and abilities.